Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis
British Journal of Pharmacology · 2026-01 · 183 (2) · 280-295
DOI: 10.1111/bph.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025-09. Verfasst von Yijun Pan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Blood-Brain Barrier, Adenosine Triphosphate, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, FightMND, Alzheimer's Association.
Abstract (Originalsprache)
Background and purpose Patients with amyotrophic lateral sclerosis (ALS) are prescribed many medications for symptomatic relief. However, how potential alterations to the blood–brain barrier (BBB) affect the brain exposure of drugs in ALS remains under‐investigated. Experimental approach We used high‐dimensional proteomic analysis, cellular metabolism, and mitochondrial functional assays to characterise isolated brain microvascular endothelial cells (BMECs) from wildtype and SOD1 G93A transgenic mice, a mouse model of familial ALS, at a late‐symptomatic age (P115–120), together with a transcardiac brain perfusion technique to assess BBB function in situ . Key results The BBB of the SOD1 G93A transgenic (TG) mice was significantly altered, including a 1.3‐fold decrease in apparent brain microvascular volume, and decreased BBB transport of 3 H‐diazepam (1.4‐fold) and 3 H‐2‐deoxy‐D‐glucose (1.2‐fold). BMEC proteomic analysis revealed multiple changes in TG mice including altered transmembrane activity, metabolism, and mitochondrial function, as revealed by gene set enrichment analysis, alongside altered glucose transporter (Glut1) abundance. These proteomic findings supported the identified increase in mitochondrial basal/ATP‐linked respiration, mitochondrial action potential, ATP production, and intracellular ATP levels in SOD1 G93A mouse BMECs. The BBB transport of 3 H‐digoxin, a specific ATP‐binding cassette efflux P‐glycoprotein (P‐gp) substrate, was reduced by 11.0% in SOD1 G93A mice. This was confirmed by a 46.7% reduction in BMEC uptake of 3 H‐digoxin, an observation that was reversed by resolving the hypermetabolic state of SOD1 G93A BMECs. Conclusion and implications These findings open possible therapeutic avenues that could be exploited to overcome P‐gp‐mediated CNS drug resistance in ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
- Department of Organ Anatomy, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
- Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
- The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
- Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
ORCID-Profile: Yijun Pan, Dana S Hutchinson, Bradley J Turner, Joseph A Nicolazzo
Förderung
- National Health and Medical Research Council
- FightMND
- Alzheimer's Association
Zitieren
APA
Pan, Y., Spiteri, A. G., Runwal, P., Sun, J., Hutchinson, D. S., Kagawa, Y., Turner, B. J., Huang, C., Shah, A. D., Schittenhelm, R. B., & Nicolazzo, J. A. (2026). Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis. British Journal of Pharmacology, 183(2), 280-295. https://doi.org/10.1111/bph.70147
Vancouver
Pan Y, Spiteri AG, Runwal P, Sun J, Hutchinson DS, Kagawa Y, et al. Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis. British Journal of Pharmacology. 2026;183(2):280-295. doi:10.1111/bph.70147
BibTeX
@article{Pan2026,
author = {Pan, Yijun and Spiteri, Alanna G and Runwal, Pranav and Sun, Jiaqi and Hutchinson, Dana S and Kagawa, Yoshiteru and Turner, Bradley J and Huang, Cheng and Shah, Anup D and Schittenhelm, Ralf B and Nicolazzo, Joseph A},
title = {Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {2},
pages = {280--295},
doi = {10.1111/bph.70147}
}
EUVIMED